Transdermal drug delivery system and uses thereof
US12329861B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 24, 2024 |
| Grant date | Jun 17, 2025 |
| Priority date | — |
| Expiry date | May 24, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2205/3576
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides transdermal drug delivery systems, methods, and platforms. In one example, the smart patch includes a drug-containing layer, a communication interface, and one or more sensors configured to detect a status change of the smart patch to the smart patch, the status change of the smart patch including one or more of removing a packaging from the smart patch and applying the smart patch to skin of the patient. The smart patch further includes a processor communicatively coupled to the one or more sensors and the communication interface, wherein the processor is configured to perform operations including automatically transiting between a plurality of working conditions based on the status change of the smart patch, the plurality of working conditions of the smart patch comprising a hibernation mode, a sleep mode, and a work mode and transmitting smart patch usage data via the communication interface.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.